Mecamylamine for the Treatment of Depression in SSRI-Treated Partial Responders
A. Purpose
1. To compare the nicotinic receptor antagonist mecamylamine (MEC) to placebo for the treatment of depressive symptoms in nicotine-dependent, cigarette smokers and in non-smokers who are maintained on, and are